InvestorBuddy

Overview of SRF followed by Concall excerpts Industry view Fluorine chemistry road ahead: Indian flurochem market is expected to grow at a CAGR of 11.6%, showing the sharpest curve across the global market. The growth in the fluorine-based intermediates segment will be the highest, more so with India moving towards in-house manufacturing of many actives and intermediates which were otherwise imported from China. SRF Business profile Chemicals ( Revenue share - 50.5%, EBIT share - 77.7% ) 1. Speciality Chemicals     -  Intermediates for AI / API / Applications     - Contract Manufacturing, Custom Research & Synthesis 2. Fluorochemicals      -  Refrigerants      -  Pharma Propellants      -  Industrial Chemicals      -  Fluoropolymers (Upcoming) Pa

Key strengths Key end user Industries Key Customers R&D Expertise Future growth projects  Projects timelines Conference call Aarti Industry Fy22-23 Q1 Fy23 Our revenue grew by 45% Y‐o‐Y to INR 2,173 crore.    EBITDA stood at INR 369 crore, higher by 18% Y‐o‐Y.    Profit after‐tax came in at INR 189 crore, an increase of 15% over last year.    Q2FY23 Revenue grew by 29% Y-o-Y to INR 1,847 Cr EBITDA improved by 5% to Rs. 267 crore; EBITDA growth is over 30% Profit after tax stood at Rs. 124 crore Q3FY23 Revenues increased by 12% Y-o-Y to Rs. 1854 crore, with exports contributing over 48% of the total revenues. EBITDA improved by 26% Y-o-Y to Rs 289 crores.  Profit after tax stood at Rs 137 crores Reason for revenue sharp jump Q1Fy23: - Revenue trajectory was steered by realization gains as well as the higher volume uptick for certain products. A substantial increase in the revenue was also on account of the robust pricing structure wherein the variation and improved prices are passed